Katzenell Dimant represents Kitov Pharmaceuticals Holdings Ltd. in publishing a prospectus for public issuance of rights to purchase its securities and registration of such securities for trade on the Tel Aviv Stock Exchange.
Kitov Pharmaceuticals is an innovative biopharmaceutical company focused on late-stage drug development.